Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

British Journal of Haematology

Volumn 104, Issue 4, 1999, Pages 695-705

  Ciudad, J ^b   San Miguel, J F ^a   Lopez Berges M C ^a   Garcia Marcos M A ^a   Gonzalez M ^a   Vazquez, L ^a   Del Canizo M C ^a   Lopez A ^a   Van Dongen, J J M ^c   Orfao, Alberto ^a,b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

B cell compartment; Flow cytometry; Immunophenotype; Minimal residual disease; Precursor B ALL

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0033029072     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01236.x     Document Type: Article

References (32)

1. Campana, D., Coustan-Smith, E. & Behm, F.G. (1941) The difinition of remission in acute leukemia with immunologic techniques. Bone Marrow Transplantation. 8, 429-437.
2. Campana, D., Coustan-Smith, E. & Janossy, G. (1990) The immunologic detection of minimal residual disease in acute leukemia. Blood, 76, 163-171.
3. Campana, D., Freitas, R.O. & Coustan-Smith, E. (1994) Detection of residual leukemia with immunologic methods: technical developments and clinical implications. Leukemia and Lymphoma, 13. (Suppl. 1), 31-34.
4. Campana, D. & Pui, C.-H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 85, 1416-1434.
5. + precursors in normal human adult bone marrow: implications for minimal residual disease detection. Haematologica, 83, 1069-1075.
6. Ciudad, J., San Miguel, J.F., López-Berges, M.C., Vidriales, B., Valverde, B., Ocqueteau, M., Mateos, G., Caballero, M.D., Hernández, J., Moro, M.J., Mateos, M.V. & Orfao, A. (1998b) Prognostic value of immunophenotypic detection of minimal residual disease (MRD) in acute lymphoblastic leukemia. Journal of Clinical Oncology, 16, 3774-3781.
7. Coustan-Smith, E., Behm, F.G., Raimondi, S.C., Rubnitz, J.C., Pui, C.H. & Campana, D. (1996) Immunologic detection of minimal residual disease in childhood acute lymphoblastic leukemia: a prospective study. (Abstract). Blood, 88, 478a.
8. Del Cañizo, M.C., Mota, A., Orfao, A., Galende, J., Caballero, M.D., García Marcos, M.A. & San Miguel, J.F. (1996) Value of colony forming unit-granulocyte macrophage assay in predicting relapse in acute myeloid leukaemia. Journal of Clinical Pathology, 49, 450-452.
9. Dworzak, M., Fritsch, G., Fleischer, C., Printz, D., Fröschl, G., Buchinger, P., Mann, G. & Gadner, H. (1997) Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow. Leukemia, 11, 1266-1273.
10. Estey, E. & Pierce, S. (1996) Routine bone marrow exam during first remission of acute myeloid leukemia. Blood, 87, 3899-3902.
11. Gore, S.D., Kastan, M.B., Goodman, S.N. & Civin, C.I. (1990) Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry. Journal of Immunological Methods, 132, 275-286.
12. Griesinger, F., Piro-Noack, M., Falk, M., Kaib, N., Püschel, M., Troff, C., Grove, D., Büchner, T., Ritter, J., Hiddemann, W. & Wörmann, B. (1997) High predictive value for relapse by three-color-flow-cytometric detection of leukemia-associated immunophenotype (LAIP) positive cells in acute lymphoblastic leukemia (ALL). (Abstract). Blood, 88, 478a.
13. Hollander, Z., Shah, V.O., Civin, C.I. & Loken, M.R. (1988) Assessment of proliferation during maturation of the B lymphoid lineage in normal human bone marrow. Blood, 71, 528-531.
14. Imamura, N. & Kuramoto, A. (1991) Detection of minimal residual disease in acute lymphoblastic leukemia by flow cytometry with monoclonal antibodies. American Journal of Hematology, 38, 332-334.
15. Lavabre-Bertrand, T., Duperray, C., Poncelet, P., Brunet, C., Exbrayat, C., Bourquard, P., Lavabre-Bertrand, C., Brochier, J., Navarro, M. & Janossy, G. (1993) Quantitation of CD24 and CD45 antigens in parallel correlated with the level of cell differentiation in normal and neoplastic B cells. Leukemia, 8, 402.
16. LeBien, T.W. & Villablanca, J.G. (1990) Ontogeny of normal human B-cell and T-cell precursors and its relation to leukemogenesis. Hematology/Oncology Clinics of North America, 4, 835-847.
17. Loken, M.R., Shah, V.O., Dattilio, K.L. & Civin, C.I. (1987) Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood, 70, 1316-1324.
18. Lúcio, P., Parreira, A., van de Beemd, M.W.M., van Lochem, E.G., Van Wering, E.R., Baars, E., Porwit-MacDonald, A., Bjorklund, E., Gaipa, G., Biondi, A., Orfao, A., Van Dongen, J.M. & San Miguel, J.F. (1998) Flow cytometric analysis of normal and leukemic bone marrow B-cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL patients. Leukemia, in press.
19. Macedo, A., Orfao, A., González, M., Vidriales, M.B., López-Berges, M.C., Martínez, A. & San Miguel, J.F. (1995) Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies. Leukemia, 9, 993-998.
20. Mirro, J.J., Jitchingman, G.R. & Stass, S.A. (1987) Lineage heterogeneity in acute leukemia: acute mixed lineage leukemia and lineage switch. The Acute Leukemias: Biologic, Diagnostic and Therapeutic Determinants (ed. by S. A. Stass), p. 383. Marcel Dekker, New York.
21. Orfao, A., Ciudad, J., Lopez-Berges, M.C., Lopez, A., Vidriales, B., Caballero, M.D., Valverde, B., Gonzalez, M. & San Miguel, J.F. (1994) Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry. Leukemia and Lymphoma, 13, (Suppl. 1), 87-90.
22. Ortega, J.J., Javier, G. & Olive, T. (1988) Treatment of hight-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84. Anales Espanao Padiatrie, 29, 72-83.
23. Potter, M.N., Cross, N.C., van Dongen, J.J., Saglio, G., Oakhill, A., Bartram, C.R. & Goldman, J.M. (1993a) Molecular evidence of minimal residual disease after treatment for leukemia and lymphoma: an updated meeting report and review. Leukemia, 7, 1302-1314.
24. Potter, M.N., Steward, C.G. & Oakhill, A. (1993b) The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 83, 412-418.
25. Pui, C.H., Raimondi, S.C., Behm, F.G., Ochs, J., Furman, W.L., Bunin, N.J., Ribeiro, R.C., Tinsley, P.A. & Mirro, J. (1986) Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia. Blood, 68, 1306-1310.
26. Ryan, D., Kossover, S., Mitchell, S., Frantz, C., Hennessy, L. & Cohen, H. (1986) Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood, 68, 417-425.
27. Stass, S., Mirro, J., Melvin, S., Pui, C.H., Murphy, S.B. & Williams, D. (1984) Lineage switch in acute leukemia. Blood, 64, 701-708.
28. Terstappen, L.W., Konemann, S., Safford, M., Loken, M.R., Zurlutter, K., Buchner, T., Hiddemann, W. & Wörmann, B. (1991) Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties. Leukemia, 5, 315-321.
29. Terstappen, L.W., Mickaels, R.A., Dost, R. & Loken, M.R. (1990) Increased light scattering resolution facilitates multidimensional flow cytometric analysis. Cytometry, 11, 506-512.
30. van Dongen, J.J., Breit, T.M., Adriaansen, H.J., Beishuizen, A. & Hooijkaas, H. (1992) Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia, 6, (Suppl. 1), 47-59.
31. Van Wering, E.R., Beishuizen, A., Roeffen, E.T.J.M., Van der Linden-Schrever, B.E.M., Verhoeven, M.A.J., Hählen, K., Hooijkaas, H. & Van Dongen, J.J.M. (1995) Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. Leukemia, 9, 1523-1533.
32. Vervoordeldonk, S.F., Merle, P.A., Behrendt, H., Steenbergen, E.J., van Leeuwen, E.F., Van Der Berg, H., Von dem Borne, A.E.G.K., Van der Schoot, C.E. & Slaper-Cortenbach, I.C.M. (1996) Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia. British Journal of Haematology, 92, 922-928.